Parameter

SSc + CVA (n = 36)

SSc + no CVA (n = 36)

p value

Sex

6 M/30 F (n = 36)

3 M/33 F (n = 36)

0.48

Race

14 AA/20 C/2 H (n = 36)

6 AA/29 C/1 H (n = 36)

N/A

Age at CVA dx

60.8 ± 13.6 (n = 35)

N/A

N/A

Age at SSc dx

51.8 ± 15.7 (n = 31)

52.6 ± 14.7 (n = 36)

0.83

Hypertension

28 yes/8 no (n = 36)

17 yes/19 no (n = 36)

0.014

Hyperlipidemia

20 yes/16 no (n = 36)

16 yes/20 no (n = 36)

0.48

Prior TIA or CVA

9 yes/26 no (n = 35)

N/A

N/A

CAD

10 yes/26 no (n = 36)

3 yes/33 no (n = 36)

0.06

Atrial fibrillation

9 yes/27 no (n = 36)

2 yes/34 no (n = 36)

0.046

Diabetes mellitus

6 yes/30 no (n = 36)

3 yes/33 no (n = 36)

0.48

Tobacco use

18 yes/18 no (n = 36)

15 yes/21 no (n = 36)

0.64

Family hx of CVA

6 yes/29 no (n = 35)

4 yes/32 no (n = 36)

0.51

Carotid disease

13 yes/13 no (n = 36)

2 yes/1 no (n = 3)

1

Type of SSc

6 D/19 L (n = 25)

7 D/29 L (n = 36)

0.76

Anti-nuclear antibody

24 pos/1 neg (n = 25)

32 pos/3 neg (n = 35)

0.63

Scl-70 antibody

1 pos/16 neg (n = 17)

4 pos/26 neg (n = 30)

0.64

ACA

10 pos/14 neg (n = 24)

17 pos/16 neg (n = 33)

0.59

Cr at time of CVA

1.23 ± 0.77 mg/dl (n = 26)

N/A

N/A

Hb at time of CVA

12.0 ± 2.21 gm/dl (n = 26)

N/A

N/A

Alb at time of CVA

3.7 ± 0.53 gm/dl (n = 24)

N/A

N/A